African-Americans with prostate cancer more likely to have family history of prostate, breast cancer

December 01, 2006

ANN ARBOR, Mich. -- African-American men with prostate cancer were more likely to report a family history of prostate cancer and breast cancer among siblings than men who did not have prostate cancer, according to researchers at the University of Michigan Comprehensive Cancer Center.

The data were part of the Flint Men's Health Study, a population-based study of African-American men ages 40-79 who live in Flint, Mich. The Flint Men's Health Study focuses specifically on African-American men as part of an effort to determine why they face a higher risk of prostate cancer than white men.

The findings from this study support previous studies that have found increased risk of prostate cancer among men reporting a brother diagnosed with the disease. Furthermore, breast cancer diagnosed among both sisters and mothers of men with prostate cancer was more often diagnosed at a younger age, suggesting premenopausal breast cancer. Both breast and prostate cancer typically occur in older populations. Results of the study appear in the November issue of Urology.

Some 121 men with prostate cancer completed surveys about their family history of cancer, including prostate cancer among the men in their family and breast cancer among the women. Another 179 control men without prostate cancer were also surveyed.

Men with prostate cancer were 4.8 times more likely to report having a brother diagnosed with prostate cancer and about four times more likely to report a sister diagnosed with breast cancer, the researchers found.

"Previous studies have suggested having a brother with prostate cancer confers higher risk than another relative, such as a father or son. But this is the first time a link has been shown between sisters with breast cancer and prostate cancer risk among African-American men," says lead study author Jennifer Beebe-Dimmer, MPH, Ph.D., assistant research scientist and lecturer in the Department of Epidemiology at the U-M School of Public Health.

"This is an important finding because the Flint Men's Health Study is one of a few studies conducted exclusively in a minority population that is known to be at high risk for developing prostate cancer," Beebe-Dimmer says. Black men are 60 percent more likely to be diagnosed with prostate cancer, regardless of family history.

Older age and a family history of prostate cancer are the primary risk factors for the disease, in both blacks and whites. A first-degree relative with prostate cancer increases a man's risk by two to four times, and the more relatives who are affected, the more the risk increases.

"Collecting a family history of prostate and breast cancer, especially among siblings, could be a key component of assessing prostate cancer risk among African-American men. A well-documented family history may signal a need for more intense prostate cancer screening," says senior study author Kathleen Cooney, M.D., professor of internal medicine and urology at the U-M Medical School.

"In addition, these findings give potential to identifying new genes associated with prostate cancer or breast cancer," adds Cooney, co-director of Urologic Oncology at the U-M Comprehensive Cancer Center.

Some 234,460 men will be diagnosed with prostate cancer this year, and 27,350 will die from the disease, according to the American Cancer Society.
-end-
In addition to Beebe-Dimmer and Cooney, study authors were Elizabeth Drake, M.D., instructor in internal medicine at U-M; Rodney Dunn, U-M Cancer Center statistician; Cathryn Bock, assistant professor at Karmanos Cancer Institute in Detroit; and James Montie, M.D., Valassis Professor of Urologic Oncology and chair of Urology at U-M.

Funding for the study was through the University of Michigan Specialized Program of Research Excellence grant for prostate cancer.

For information about prostate cancer, call U-M's Cancer AnswerLine at 800-865-1125 or visit www.cancer.med.umich.edu/cancertreat/urologiconcology/prostate_cancer.shtml.

Reference: Urology, Vol. 68, Issue 5, pp. 1072-1076

University of Michigan Health System

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.